ImplicitBio Profile Banner
ImplicitBioscience Profile
ImplicitBioscience

@ImplicitBio

Followers
32
Following
1
Media
2
Statuses
8

Developing groundbreaking immunotherapy treatments for serious - often fatal - diseases. Join the conversation πŸ‘‰ #implicitbioscience #IC14 #MND #ALS #Covid19

Joined February 2021
Don't wanna be here? Send us removal request.
@ImplicitBio
ImplicitBioscience
24 days
Our pioneering work in cardioimmunology has captured national attention, with The Australian today reporting on the publication of our foundational cardiology data in the Journal of the American College of Cardiology (JACC). Take a look:
0
0
0
@ImplicitBio
ImplicitBioscience
4 years
JOURNAL ARTICLE | @MedicineLWW has published a report of the first safety and biomarker study of #IC14 in patients with #ALS #MND. See it here πŸ‘‰ https://t.co/3Upl2J4Rhy #MedicalResearch #biotech #pharma #ImplicitBioscience
0
1
1
@ImplicitBio
ImplicitBioscience
4 years
We’re proud to share a feature story written by a respected US biotechnology commentator. It captures the fascinating history of #ImplicitBioscience – including our why, how and what next – as we test the full capabilities of our IC14 antibody πŸ‘‰ https://t.co/s3g2A4cZPF #biotech
0
1
4
@ImplicitBio
ImplicitBioscience
5 years
Did you see the @couriermail today? @janellehmiles explains how #IC14 works πŸ‘‰
0
2
7
@ImplicitBio
ImplicitBioscience
5 years
Thank you to @abcbrisbane for inviting our CSO Prof Ian Frazer into studio today for an interview with @Loretta_Ryan and @zonca (and a later cross on @abcnews 24 too) - see here πŸ‘‰
Tweet card summary image
abc.net.au
A Brisbane biotech company createsΒ an anti-inflammatory drug which is being trialled as a potential treatment for severely-ill COVID-19 patients in the United States in a bid to prevent people dying...
0
3
6
@ImplicitBio
ImplicitBioscience
5 years
Our CSO Professor Ian Frazer appeared on @sunriseon7 this morning to discuss the commencement of our Phase 2 clinical trials for #IC14 in #coronavirus patients in the US. Take a look πŸ‘‰
0
1
2
@ImplicitBio
ImplicitBioscience
5 years
CLINICAL MILESTONE | Our lead therapeutic candidate, #IC14 will be tested as part of a Phase 2 clinical trial in COVID-19 patients in US hospitals. We're hosting a media call at @TRI_info today, learn more πŸ‘‰ https://t.co/qjAPnU7OBU @NIAIDNews #research #biotech #lifesciences
0
2
6